Alzheimer's Disease Trial, Recruiting NCT06057909 Sponsor: Mayo Clinic Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06057909
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose primary language is English.
  • People who are willing to take part in health and thinking/memory assessments, as well as brain MRI scans and EEG brain wave recordings.
  • People who have a study partner (such as a family member or close friend) who knows them well and can speak to how they manage day-to-day life — having a partner is encouraged but not strictly required (confirm with trial site).
  • People who are either healthy, or who have been diagnosed with Lewy body disease or Alzheimer's disease by a qualified specialist neurologist.
  • People who are able to understand and agree to take part in the study, and follow the study procedures. Extra time and support are provided during the consent process, including for people with thinking or memory difficulties, together with a caregiver or legal guardian.
  • People who are able to attend study visits, with their ongoing participation reviewed at each visit based on their health and the wishes of their family or caregivers.
  • People who are aware that a copy of their signed consent forms will be provided to them.
  • People who understand they are free to leave the study at any time.

Who may not be able to join:

  • People with serious vision or hearing problems that would make it difficult to take part in the study activities.
  • People with major medical or psychiatric conditions that would limit their ability to take part.
  • People with a history of other significant brain or neurological conditions, including stroke, epilepsy, brain infections (such as meningitis or encephalitis), toxic or metabolic brain disorders, serious head injury, brain tumours or other structural brain problems, or other movement disorders such as essential tremor, dystonia, chorea, multiple system atrophy, progressive supranuclear palsy, or corticobasal syndrome.
  • People who have an implanted electrical device in their body, such as a heart pacemaker, deep brain stimulator, or other neurostimulator, as these are not safe for MRI scanning.
  • People who have a certain type of metal clip inside their body, such as a surgical clip used to treat a brain aneurysm, as this may not be safe for MRI scanning.
  • People who experience severe anxiety in enclosed spaces (claustrophobia), as this would prevent MRI participation.
  • Women who are pregnant, possibly pregnant, or breastfeeding.
  • Women of childbearing age who are unable or unwilling to have a pregnancy test before taking part, due to unknown risks to a developing baby.
  • People with a history of metalwork involving cutting processes such as grinding, filing, shaving, or threading, or a history of an eye injury involving metal — unless a doctor has already cleared them for MRI with documented imaging records.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shannon Chiu, MD, Mayo Clinic

Phone: 480-301-6279

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
5 April 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Diffusion-weighted MRI (dMRI); Electroencephalography (EEG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov